Skip to Main Content

Paper Details

Sodium-glucose cotransporter 2 (SGLT-2) inhibitors and microvascular outcomes in patients with type 2 diabetes: systematic review and meta-analysis.
J Endocrinol Invest
23
2020
Author NameAffiliation
Ann M FarrellMayo Clinic
Victor M MontoriKnowledge and Evaluation Research Unit in Endocrinology, Mayo Clinic
Victor M MontoriMayo Clinic
  • 1 - 3

Datasets

Release 1.2